MedTrace Logo

Breathing Adapted Radiotherapy for Mediastinal Lymphoma

NCT00928096 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 22

Last updated 2014-10-21

No results posted yet for this study

Summary

In this study, radiation therapy plans will be made for 20 consecutive patients with mediastinal Hodgkin lymphoma or aggressive non-Hodgkin lymphoma. One plan is done using a breathing adapted pre-chemo PET-CT scan fused with a post-chemo planning CT scan and another plan is done using the standard procedure with pre-chemo PET-CT fused with post-chemo planning CT scan. Dose levels to the lymphoma and to the organs of risk will be compared in each patient. The best radiation therapy plan will be used to treat the patient.

Conditions

Sponsors & Collaborators

  • University of Copenhagen

    collaborator OTHER

  • Peter Meidahl Petersen

    lead OTHER

Principal Investigators

  • Peter M Petersen, MD, Ph.D · Rigshospitalet, Denmark

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-06-30
Primary Completion
2013-05-31
Completion
2013-05-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00928096 on ClinicalTrials.gov